Live from the NIH registry
Studies recruiting near Champaign right now
Top 25 of 173 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Champaign, IL — Champaign, Illinois (1.6 mi)
· Sponsor: Mediar Therapeutics
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Christie Clinic — Champaign, Illinois (1.6 mi)
· Sponsor: Alveus Therapeutics, Inc.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Carle Health — Urbana, Illinois (3.5 mi)
· Sponsor: Paradigm Health
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Multiple conditions
Phase 2
Interventional 120 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
Spinal Cord Injuries (SCI), Multiple Sclerosis
N/A
Interventional 120 participants sought
Disability Participation and Quality of Life (DPQOL) Laboratory — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms
Alcohol Drinking, Alcohol Intoxication
N/A
Observational 240 participants sought
University of Illinois at Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Stable Isotopes- Adults With Obesity
Obese Patients (BMI ≥ 30 kg/m²), Glucose Metabolism
N/A
Interventional 8 participants sought
Freer Hall - University of Illinois — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 165 participants sought
Christie Clinic on University /ID# 277871 — Champaign, Illinois (1.6 mi)
· Sponsor: AbbVie
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Obesity or Overweight, Weight-Related Comorbidity
Phase 3
Interventional 500 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Wake Forest University Health Sciences
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Dysphagia, Stroke
Phase 2
Interventional 120 participants sought
University of Illinois Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)